Back to LCTX
Ashurst Perkins Coie Trust Co → LCTX
Ashurst Perkins Coie Trust Co LCTX Position History
Lineage Cell Therapeutics, Inc.
Quarters held
4
Latest value
$337K
Q3 2026
Peak value
$427K
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $345K |
| Q1 2026 | $323K |
| Q2 2026 | $427K |
| Q3 2026 | $337K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $337K | 9.9K | — | — |
| Q2 2026 | $427K | 9.9K | — | — |
| Q1 2026 | $323K | 9.9K | — | — |
| Q4 2025 | $345K | 9.9K | — | — |
Other funds holding LCTX
$537.7M
$391.7M
$332.9M
$299.1M
$259.1M
$242.5M
$238.9M
$219.8M
Other Ashurst Perkins Coie Trust Co positions
VGES
$52.6MVANGUARD FTSE DEVELOPED MKTS ETF
VGES
$51.5MVANGUARD FTSE DEVELOPED MKTS ETF
VGES
$49.4MVANGUARD FTSE DEVELOPED MKTS ETF
VGES
$47.4MVANGUARD FTSE DEVELOPED MKTS ETF
VGES
$46.1MVANGUARD MID-CAP ETF
VGES
$44.7MVANGUARD MORNINGSTAR MID-CAP ETF
VGES
$41.2MVANGUARD MID-CAP ETF
VGES
$41.2MVANGUARD MID-CAP ETF